Back

Panel discussion

13 April 2026 (15:00 - 15:15)
Organised by: Logo
Congress Presentation Part of: Targeting advanced atrial fibrillation: the Hybrid AF Therapies advantage Rhythm Control, Hybrid Therapy EHRA Premium Access EHRA 2026 European Heart Rhythm Association (EHRA)

3 More presentations in this session

Presentation thumbnail
The advantage of epi-endocardial ablation in advanced atrial fibrillation
Doctor N. Sood (Fall River, US)
Slides Video
Presentation thumbnail
Durability matters: guideline changing data - long term results
Doctor A. Porta-Sanchez (Barcelona, ES)
Slides Video
Presentation thumbnail
Which patients to refer to Hybrid AF Therapies: why and when?
Professor P. Sommer (Bad Oeynhausen, DE)
Slides Video

Access the full session

Session thumbnail
Targeting advanced atrial fibrillation: the Hybrid AF Therapies advantage
Video

The Event

Event poster

EHRA 2026

13 April 2026 15:00 CET
You may be interested in
thumbnail
Congress Session
Targeting advanced atrial fibrillation: the Hybrid AF Therapies advantage
thumbnail
Congress Presentation
Longstanding persistent atrial fibrillation ablation: discussion
thumbnail
Congress Presentation
The most personalised approach for ablation of persistent atrial fibrillation: discussion

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources